Is Ginseng Stress Randomized Trial safe?

Updated July 2026

Quick Answer

Ginseng Stress Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis.

Key Takeaways

  • 01Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis. [Tang T (2026)]
  • 02Ginsenosides are the prime pharmacologically active compounds responsible for the medicinal properties of ginseng, which are also found in many otherspecies, includingand. [Cortés Hernán (2026)]
  • 03Some studies have reported reduced plasma concentrations of warfarin and enhanced aspirin bioavailability after ginseng intake, indicating possible pharmacokinetic and pharmacodynamic interactions. [Cortés Hernán (2026)]
  • 04Alzheimer's disease (AD) is a result of a neurodegenerative process, which is associated with beta‐amyloid deposition and neurofibrillary tangles formation (Wang et al. ). [Cortés Hernán (2026)]
The current Migaku evidence database contains 2 reusable source documents for Ginseng Stress Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis. [Tang T (2026); evidence level 1] - Ginsenosides are the prime pharmacologically active compounds responsible for the medicinal properties of ginseng, which are also found in many otherspecies, includingand. [Cortés Hernán (2026); evidence level 3] - Some studies have reported reduced plasma concentrations of warfarin and enhanced aspirin bioavailability after ginseng intake, indicating possible pharmacokinetic and pharmacodynamic interactions. [Cortés Hernán (2026); evidence level 3] - Alzheimer's disease (AD) is a result of a neurodegenerative process, which is associated with beta‐amyloid deposition and neurofibrillary tangles formation (Wang et al. ). [Cortés Hernán (2026); evidence level 3] - AD Akt AMP AMPK APP/Aβ AUC BBB [Ca] CaN CaSR Cl C CNS CYP CYP‐7A DMT1 DMT2 EMT FoxO1 FSH G6Pase GLUT4 GRg1 GSK‐3β Haspin HD HO‐1 HSC IC IL‐1β LDL LH LPS MAPKs MPTP mRNA MRT NF‐κB nNOS NO OGD PC12 PD PDGF PEPCK PINK PPARγ PPD SAMP8 SMAD Smad7 SNpc SREBP‐1C T TGF‐β1 TLR T TNF‐α V VEGF Panax ginseng P. [Cortés Hernán (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Efficacy of plant extracts in heart failure patients: a systematic review and network meta-analysis.
  2. Ginsenoside Rg1 as a Multifunctional Therapeutic Agent: Pharmacological Properties, Molecular Mechanisms and Clinical Perspectives in Complementary Medicine